Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

164 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma.
Merz M, Hielscher T, Schult D, Mai EK, Raab MS, Hillengass J, Seckinger A, Hose D, Granzow M, Jauch A, Goldschmidt H. Merz M, et al. Among authors: hielscher t. Leukemia. 2020 Apr;34(4):1192-1196. doi: 10.1038/s41375-019-0634-2. Epub 2019 Nov 11. Leukemia. 2020. PMID: 31712777 Free PMC article. No abstract available.
How to evaluate agreement between quantitative measurements.
Kopp-Schneider A, Hielscher T. Kopp-Schneider A, et al. Among authors: hielscher t. Radiother Oncol. 2019 Dec;141:321-326. doi: 10.1016/j.radonc.2019.09.004. Epub 2019 Sep 25. Radiother Oncol. 2019. PMID: 31563409
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia.
van Tilburg CM, Milde T, Witt R, Ecker J, Hielscher T, Seitz A, Schenk JP, Buhl JL, Riehl D, Frühwald MC, Pekrun A, Rossig C, Wieland R, Flotho C, Kordes U, Gruhn B, Simon T, Linderkamp C, Sahm F, Taylor L, Freitag A, Burhenne J, Foerster KI, Meid AD, Pfister SM, Karapanagiotou-Schenkel I, Witt O. van Tilburg CM, et al. Among authors: hielscher t. Clin Epigenetics. 2019 Dec 10;11(1):188. doi: 10.1186/s13148-019-0775-1. Clin Epigenetics. 2019. PMID: 31823832 Free PMC article. Clinical Trial.
IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M, Loktev A, Wefers AK, Altmann A, Paech D, Adeberg S, Windisch P, Hielscher T, Flechsig P, Floca R, Leitz D, Schuster JP, Huber PE, Debus J, von Deimling A, Lindner T, Haberkorn U. Röhrich M, et al. Among authors: hielscher t. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2569-2580. doi: 10.1007/s00259-019-04444-y. Epub 2019 Aug 6. Eur J Nucl Med Mol Imaging. 2019. PMID: 31388723
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma.
Merz M, Hielscher T, Mai EK, Seckinger A, Hose D, Jauch A, Sauer S, Luntz S, Bertsch U, Raab MS, Neben K, Salwender H, Blau IW, Lindemann HW, Dürig J, Scheid C, Haenel M, Weisel K, Weber T, Delorme S, Goldschmidt H, Hillengass J. Merz M, et al. Among authors: hielscher t. Blood Cancer J. 2019 Aug 27;9(9):71. doi: 10.1038/s41408-019-0235-3. Blood Cancer J. 2019. PMID: 31455768 Free PMC article. No abstract available.
Marginal variable screening for survival endpoints.
Edelmann D, Hummel M, Hielscher T, Saadati M, Benner A. Edelmann D, et al. Among authors: hielscher t. Biom J. 2020 May;62(3):610-626. doi: 10.1002/bimj.201800269. Epub 2019 Aug 26. Biom J. 2020. PMID: 31448463 Review.
Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma.
Hose D, Rème T, Meissner T, Moreaux J, Seckinger A, Lewis J, Benes V, Benner A, Hundemer M, Hielscher T, Shaughnessy JD Jr, Barlogie B, Neben K, Krämer A, Hillengass J, Bertsch U, Jauch A, De Vos J, Rossi JF, Möhler T, Blake J, Zimmermann J, Klein B, Goldschmidt H. Hose D, et al. Among authors: hielscher t. Blood. 2009 Apr 30;113(18):4331-40. doi: 10.1182/blood-2008-09-178350. Epub 2009 Jan 26. Blood. 2009. PMID: 19171872 Free PMC article.
164 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page